{"id":"https://openalex.org/W2809769905","doi":"https://doi.org/10.1038/s41416-018-0168-9","title":"Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy","display_name":"Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy","publication_year":2018,"publication_date":"2018-07-01","ids":{"openalex":"https://openalex.org/W2809769905","doi":"https://doi.org/10.1038/s41416-018-0168-9","mag":"2809769905","pmid":"https://pubmed.ncbi.nlm.nih.gov/29973670","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6048096"},"language":"en","primary_location":{"id":"doi:10.1038/s41416-018-0168-9","doi":"https://doi.org/10.1038/s41416-018-0168-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-018-0168-9","pdf_url":"https://www.nature.com/articles/s41416-018-0168-9.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/s41416-018-0168-9.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5005586319","display_name":"Frantz Dupuis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Frantz Dupuis","raw_affiliation_strings":["Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017625077","display_name":"Laurence Lamant","orcid":"https://orcid.org/0000-0002-1123-7658","observed_orcids":["https://orcid.org/0000-0002-1123-7658"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Laurence Lamant","raw_affiliation_strings":["Department of Pathology, Oncopole de Toulouse, 31100, Toulouse, France","Universit\u00e9 Paul-Sabatier, 31400, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Oncopole de Toulouse, 31100, Toulouse, France","institution_ids":[]},{"raw_affiliation_string":"Universit\u00e9 Paul-Sabatier, 31400, Toulouse, France","institution_ids":["https://openalex.org/I134560555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076940642","display_name":"\u00c9milie Gerard","orcid":"https://orcid.org/0000-0003-1765-461X","observed_orcids":["https://orcid.org/0000-0003-1765-461X","https://orcid.org/0000-0003-3530-4605"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210111110","display_name":"H\u00f4pital Saint-Andr\u00e9","ror":"https://ror.org/021959v84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Emilie Gerard","raw_affiliation_strings":["Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004304273","display_name":"Nouritza Torossian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nouritza Torossian","raw_affiliation_strings":["Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I3019448017"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007368768","display_name":"L\u00e9onor Chaltiel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Leonor Chaltiel","raw_affiliation_strings":["Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5003424696","display_name":"Thomas Filleron","orcid":"https://orcid.org/0000-0003-0724-0659","observed_orcids":["https://orcid.org/0000-0003-0724-0659"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Filleron","raw_affiliation_strings":["Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Biostatistics, Oncopole de Toulouse, 31100, Toulouse, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006277322","display_name":"Marie Beylot-Barry","orcid":"https://orcid.org/0000-0001-6150-1229","observed_orcids":["https://orcid.org/0000-0001-6150-1229"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210111110","display_name":"H\u00f4pital Saint-Andr\u00e9","ror":"https://ror.org/021959v84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie Beylot-Barry","raw_affiliation_strings":["Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France","INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]},{"raw_affiliation_string":"INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055627811","display_name":"Caroline Dutriaux","orcid":"https://orcid.org/0000-0002-9836-5168","observed_orcids":["https://orcid.org/0000-0002-9836-5168"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210111110","display_name":"H\u00f4pital Saint-Andr\u00e9","ror":"https://ror.org/021959v84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Caroline Dutriaux","raw_affiliation_strings":["Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010934547","display_name":"Sorilla Prey","orcid":"https://orcid.org/0000-0003-0272-2640","observed_orcids":["https://orcid.org/0000-0003-0272-2640"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]},{"id":"https://openalex.org/I4210111110","display_name":"H\u00f4pital Saint-Andr\u00e9","ror":"https://ror.org/021959v84","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Sorilla Prey","raw_affiliation_strings":["Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, H\u00f4pital Saint-Andr\u00e9 (CHU de Bordeaux), 33000, Bordeaux, France","institution_ids":["https://openalex.org/I3018323443","https://openalex.org/I4210111110"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007174142","display_name":"Audrey Gros","orcid":"https://orcid.org/0000-0002-8958-3745","observed_orcids":["https://orcid.org/0000-0002-8958-3745"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Audrey Gros","raw_affiliation_strings":["Department of Tumour Biology and Tumour Bank, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France","INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Tumour Biology and Tumour Bank, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075531603","display_name":"Marie\u2010Laure Julli\u00e9","orcid":"https://orcid.org/0000-0002-0048-6501","observed_orcids":["https://orcid.org/0000-0002-0048-6501"]},"institutions":[{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-Laure Jullie","raw_affiliation_strings":["Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France","institution_ids":["https://openalex.org/I3018323443"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067794998","display_name":"Nicol\u00e1s Meyer","orcid":"https://orcid.org/0000-0003-4519-8666","observed_orcids":["https://orcid.org/0000-0003-4519-8666"]},"institutions":[{"id":"https://openalex.org/I134560555","display_name":"Universit\u00e9 Toulouse III - Paul Sabatier","ror":"https://ror.org/02v6kpv12","country_code":"FR","type":"education","lineage":["https://openalex.org/I134560555","https://openalex.org/I4405258862"]},{"id":"https://openalex.org/I3019448017","display_name":"Centre Hospitalier Universitaire de Toulouse","ror":"https://ror.org/017h5q109","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3019448017"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nicolas Meyer","raw_affiliation_strings":["Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, Paul-Sabatier-Toulouse III University (CHU de Toulouse), 31059, Toulouse, France","institution_ids":["https://openalex.org/I134560555","https://openalex.org/I3019448017"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5017989408","display_name":"B\u00e9atrice Vergier","orcid":"https://orcid.org/0000-0002-3498-3143","observed_orcids":["https://orcid.org/0000-0002-3498-3143"]},"institutions":[{"id":"https://openalex.org/I15057530","display_name":"Universit\u00e9 de Bordeaux","ror":"https://ror.org/057qpr032","country_code":"FR","type":"education","lineage":["https://openalex.org/I15057530"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I3018323443","display_name":"Centre Hospitalier Universitaire de Bordeaux","ror":"https://ror.org/01hq89f96","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018323443"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"B\u00e9atrice Vergier","raw_affiliation_strings":["Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France. beatrice.vergier@chu-bordeaux.fr","INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France. beatrice.vergier@chu-bordeaux.fr","INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, H\u00f4pital Haut-L\u00e9v\u00eaque (CHU de Bordeaux), 33604, Pessac, France. beatrice.vergier@chu-bordeaux.fr","institution_ids":["https://openalex.org/I3018323443"]},{"raw_affiliation_string":"INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France. beatrice.vergier@chu-bordeaux.fr","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]},{"raw_affiliation_string":"INSERM U1053 Team 1 (universit\u00e9 de Bordeaux), 33076, Bordeaux, France","institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5017989408"],"corresponding_institution_ids":["https://openalex.org/I15057530","https://openalex.org/I154526488","https://openalex.org/I3018323443"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":0.7306,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.72873595,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"119","issue":"2","first_page":"193","last_page":"199"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0034000000450760126,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/metastatic-melanoma","display_name":"metastatic melanoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/anti-pd-1-therapy","display_name":"anti-PD-1 therapy","score":0.9909999966621399},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.9190000295639038},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9789999723434448},{"id":"https://openalex.org/keywords/nras-mutation","display_name":"NRAS mutation","score":0.8100000023841858},{"id":"https://openalex.org/keywords/metachronous-metastases","display_name":"metachronous metastasis","score":0.9919999837875366},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.7699999809265137},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9390000104904175},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.843999981880188},{"id":"https://openalex.org/keywords/tumor-infiltrating-immune-cells","display_name":"tumor-infiltrating immune cells","score":0.7689999938011169}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7958481311798096},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.764056921005249},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7002578377723694},{"id":"https://openalex.org/C21790070","wikidata":"https://www.wikidata.org/wiki/Q18030215","display_name":"Neuroblastoma RAS viral oncogene homolog","level":5,"score":0.6577838659286499},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5966032147407532},{"id":"https://openalex.org/C2775858924","wikidata":"https://www.wikidata.org/wiki/Q18034009","display_name":"CD163","level":4,"score":0.5622053742408752},{"id":"https://openalex.org/C43100952","wikidata":"https://www.wikidata.org/wiki/Q654612","display_name":"Histiocyte","level":2,"score":0.5586714744567871},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5190842151641846},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.4906231462955475},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.4822829067707062},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4732782542705536},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.41275620460510254},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3953062891960144},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.35523760318756104},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.2822132110595703},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08273246884346008},{"id":"https://openalex.org/C2779244956","wikidata":"https://www.wikidata.org/wiki/Q184204","display_name":"Macrophage","level":3,"score":0.07558068633079529},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.0},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077982","descriptor_name":"Progression-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000098902","descriptor_name":"CD163 Antigen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006644","descriptor_name":"Histiocytes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006644","descriptor_name":"Histiocytes","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007167","descriptor_name":"Immunotherapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008545","descriptor_name":"Melanoma","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D008565","descriptor_name":"Membrane Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011956","descriptor_name":"Receptors, Cell Surface","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D015214","descriptor_name":"Antigens, Differentiation, Myelomonocytic","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015703","descriptor_name":"Antigens, CD","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D016609","descriptor_name":"Neoplasms, Second Primary","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D020558","descriptor_name":"GTP Phosphohydrolases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D060890","descriptor_name":"B7-H1 Antigen","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D061026","descriptor_name":"Programmed Cell Death 1 Receptor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41416-018-0168-9","doi":"https://doi.org/10.1038/s41416-018-0168-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-018-0168-9","pdf_url":"https://www.nature.com/articles/s41416-018-0168-9.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:6048096","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6048096","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:29973670","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29973670","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41416-018-0168-9","doi":"https://doi.org/10.1038/s41416-018-0168-9","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41416-018-0168-9","pdf_url":"https://www.nature.com/articles/s41416-018-0168-9.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2809769905.pdf","grobid_xml":"https://content.openalex.org/works/W2809769905.grobid-xml"},"referenced_works_count":23,"referenced_works":["https://openalex.org/W196761210","https://openalex.org/W1504601414","https://openalex.org/W1809627231","https://openalex.org/W1889335134","https://openalex.org/W1975992327","https://openalex.org/W2022465587","https://openalex.org/W2089536793","https://openalex.org/W2112121482","https://openalex.org/W2118982164","https://openalex.org/W2128035403","https://openalex.org/W2160834915","https://openalex.org/W2166662937","https://openalex.org/W2254907138","https://openalex.org/W2256549280","https://openalex.org/W2281321365","https://openalex.org/W2286032567","https://openalex.org/W2499809487","https://openalex.org/W2527905628","https://openalex.org/W2554186605","https://openalex.org/W2560367415","https://openalex.org/W2572174216","https://openalex.org/W2594615455","https://openalex.org/W4234603135"],"related_works":["https://openalex.org/W2902448025","https://openalex.org/W2472955873","https://openalex.org/W2469910489","https://openalex.org/W2925916734","https://openalex.org/W4211025067","https://openalex.org/W2617468510","https://openalex.org/W4405444358","https://openalex.org/W3202916228","https://openalex.org/W2970435082","https://openalex.org/W2896078600"],"abstract_inverted_index":{"BACKGROUND:":[0],"Prescribing":[1],"anti-programmed":[2],"death-1":[3],"(PD-1)":[4],"immunotherapy":[5],"for":[6,160],"advanced":[7],"melanoma":[8,60],"is":[9,23,27],"currently":[10],"not":[11,28],"restricted":[12],"by":[13],"any":[14],"biomarker":[15],"assessment.":[16],"Determination":[17],"of":[18,41,110],"programmed":[19],"death-ligand-1":[20],"(PD-L1)-expression":[21],"status":[22,98],"technically":[24],"challenging":[25],"and":[26,75,113,135,145],"mandatory,":[29],"because":[30],"negative":[31],"tumours":[32],"also":[33],"achieve":[34],"therapeutic":[35,51,158],"responses.":[36],"However,":[37],"reproducible":[38,153],"biomarkers":[39,154],"predictive":[40],"a":[42],"response":[43,79,84],"to":[44,49,64],"anti-PD-1":[45],"therapy":[46],"could":[47,155],"contribute":[48],"improving":[50],"decision-making.":[52],"METHODS:":[53],"This":[54],"retrospective":[55],"study":[56],"on":[57],"70":[58],"metastatic":[59],"patients":[61,161],"was":[62],"undertaken":[63],"evaluate":[65],"the":[66,76],"relationships":[67],"between":[68],"clinical,":[69],"histological,":[70],"immunohistochemical":[71],"and/or":[72,96],"molecular":[73],"criteria,":[74],"6-month":[77],"objective":[78,83],"rate.":[80],"RESULTS:":[81],"Better":[82],"rates":[85],"were":[86,128],"associated":[87,129],"with":[88,130,138,162],"metachronous":[89,136],"metastases":[90,137],"(P":[91,99,107,116,125,142,147],"=":[92,100,108,117,126,143,148],"0.04),":[93],"PD-L1":[94],"tumour-":[95],"immune-cell":[97],"0.01),":[101],"CD163+":[102,120],"histiocytes":[103,121],"at":[104,122],"advancing":[105,123],"edges":[106,124],"0.009)":[109],"primary":[111],"melanomas":[112],"NRAS":[114],"mutation":[115],"0.019).":[118],"Moreover,":[119],"0.04)":[127],"longer":[131,139],"progression-free":[132],"survival":[133,141],"(PFS),":[134],"overall":[140],"0.02)":[144],"PFS":[146],"0.049).":[149],"CONCLUSIONS:":[150],"Combining":[151],"these":[152],"help":[156],"improve":[157],"decision-making":[159],"progressive":[163],"disease.":[164]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-07-10T00:00:00"}